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Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) 
are widely used to relieve pain, reduce fever and inhibit 
inflammation. NSAIDs function mainly through inhibition of 
cyclooxygenase (COX). Growing evidence suggests that 
NSAIDs also have immunomodulatory effects on T and B 
cells. Here we examined the effects of NSAIDs on the anti-
gen presenting function of dendritic cells (DCs). Methods: 
DCs were cultured in the presence of aspirin or ibuprofen, 
and then allowed to phagocytose biodegradable micro-
spheres containing ovalbumin (OVA). After washing and fix-
ing, the efficacy of OVA peptide presentation by DCs was 
evaluated using OVA-specific CD8 and CD4 T cells. Results: 
Aspirin and ibuprofen at high concentrations inhibited both 
MHC class I and class II-restricted presentation of OVA in 
DCs. In addition, the DCs generated in the presence of low 
concentrations of the drugs exhibit a profoundly suppressed 
capability to present MHC-restricted antigens. Aspirin and 
ibuprofen did not inhibit the phagocytic activity of DCs, the 
expression level of total MHC molecules and co-stimulatory 
molecules on DCs. Ibuprofen rather increased the expression 
level of total MHC molecules and co-stimulatory molecules 
on DCs. Conclusion: These results demonstrate that aspirin 
and ibuprofen inhibit the intracellular processing event of the 
phagocytosed antigen, and further suggest that prolonged 
administration of NSAIDs in high doses may impair the capa-
bility of DCs to present antigens in asiociation with MHC 
molecules. 
[Immune Network 2010;10(3):92-98]
INTRODUCTION
Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit cyclo-
oxygenase (COX), the rate-limiting enzyme for the synthesis 
of prostaglandins (1,2). Two COX isoforms have been identi-
fied  in  eukaryotic  cells,  COX-1  and  COX-2.  COX-1  is  con-
stitutively expressed in most cells, while COX-2 is inducibly 
expressed  in  a  more  limited  array  of  cells  at  inflammatory 
sites (3,4). Thus, the ability of NSAIDs to inhibit COX-2 activ-
ity may explain their therapeutic effects as anti-inflammatory 
drugs (2-5). Most of the NSAIDs that are currently in clinical 
use inhibit both COX-1 and COX-2, although some inhibit one 
i s o s o m e  t o  a  g r e a t e r  e x t e n t  t h a n  t h e  o t h e r  ( 6 ) .  
    There  is  growing  evidence  showing  that  NSAIDs  may 
have immunomodulatory activities not apparently related to 
the  inhibition  of  prostaglandin  synthesis.  NSAIDs  were 
shown to inhibit T cell proliferation, expression of activa-
tion-related  molecules  such  as  CD25  and  CD71,  and  the 
production  of  cytokines such as IL-2, IFN-γ and TNF-α 
(7-9).  Aspirin  and  salicylates  have  been  shown  to  inhibit 
NF-κB  activation,  which  is  indispensible  in  the  tran-
scription of pro-inflammatory cytokines (10,11). Ibuprofen, 
indomethacin and fenoprofen have also been shown to in-
hibit PMA-induced cytokine synthesis in human peripheral 
blood lymphocytes (12). It has also been demonstrated that 
aspirin, ibuprofen, tylenol and naproxen suppress antibody 
production  in  human  peripheral  blood  mononuclear  cells 
(13).  In  support  of  the  immunomodulatory  activity  of Cox Inhibitors Block MHC-restricted Antigen Presentation
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NSAIDs on lymphocytes, it has been shown that COX-1 is 
constitutively expressed on T cells, whereas the expression 
of  COX-2  is  inducibly  up-regulated  in  T  cells  upon  stim-
ulation  (9,14).
    In  the  present  study,  we  examined  the  effects  of  aspirin 
and  ibuprofen  on  the  MHC-restricted  presentation  of  the 
exogenous antigen, ovalbumin (OVA), in DCs, which are the 
most important accessory cells for the activation of naïve T 
cells and the generation of primary T cell responses (15). We 
found that the drugs inhibit MHC-restricted exogenous anti-
gen presentation, especially when the DCs are exposed to the 
drugs during early the stage of differentiation. Since T cells 
can  only  recognize  antigens  presented  on  MHC  molecules, 
the inhibition of MHC-restricted antigen processing pathways 
by the drugs may have profound implications in explaining 
the immunomodulatory effects of the drugs such as the in-
hibition of immune activation and the production of pro-in-
flammatory  cytokines  by  T  cells.
MATERIALS AND METHODS
Cells and cell lines
T  cell  hybridomas,  B3Z86/90.14  (B3Z)  and  DOBW,  were 
kindly provided by Dr. Nilabh Shastri (University of Califor-
n i a ,  B e r k e l e y ,  C A )  a n d  b y  D r .  C l i f f o r d  V .  H a r d i n g  ( C a s e  
Western  Reserve  University,  Cleveland,  OH),  respectively 
(16,17).  The  DC  cell  line  (DC2.4)  was  obtained  from  the 
Dana-Farber  Cancer  Institute,  Boston,  MA,  USA  (18). 
Generation of bone marrow-derived DCs (BM-DCs)
D C s  w e r e  g e n e r a t e d  f r o m  t o t a l  B M  c e l l s  a s  d e s c r i b e d  p r e -
viously  (19).  Briefly,  BM  cells  obtained  from  femurs  of 
BALB/c mmice were cultured in a 6-well plates (5×10
6/well) 
in a culture medium supplemented with 200 U/ml rmGM-CSF. 
At days 3 and 4 from the initiation of the culture, nonadherent 
cells  were  discarded  by  replacing  the  culture  medium  with 
fresh medium containing the cytokines after gentle shaking. 
D C s  w e r e  h a r v e s t e d  b y  g e n t l e  p i p e t t i n g  a t  d a y  6 .
Preparation of OVA-microspheres
Microspheres  containing  OVA  were  prepared  using  a  sol-
vent-evaporation method, as described previously (20), using 
OVA dissolved in 3% polyvinyl alcohol (4 mg/ml) and poly 
(DL-lactide-co-glycolide)  (PLGA;  lactide：glycolide=50：50; 
Sigma-Aldrich, St. Louis, MO, USA) dissolved in a mixture of 
acetone and ethanol (9：1) (5%). The concentration of OVA 
was determined by micro-bicinchoninic acid assay kit (Pierce, 
Rockford, IL) according to the manufacturer’s instructions af-
ter lysing the microspheres in a lysis buffer containing 0.1% 
SDS  and  0.1  N  NaOH.  For  phagocytosis  assays,  micro-
pheres containing both OVA and fluorescein isothiocyanate 
(FITC) were prepared by adding FITC (final, 5 mg/ml) to 
a  mixture  of  acetone  and  ethanol  (9：1)  together  with 
PLGA  (final,  5%).
MHC class I-restricted presentation assay
LacZ T cell activation assays were used to assess the amounts 
of  cross-presented  OVA  peptides,  as  previously  described 
(20). Briefly, DCs were cultured in the presence of different 
concentrations of aspirin (Sigma-Aldich) or ibuprofen (Sigma- 
Aldich) for 18 h in 96-well plates (1×10
5/well), and then add-
ed with OVA-microspheres (50μg/ml as OVA). After 2 h in-
cubation at 37
oC, the plate was washed twice with 300μl/ 
well of pre-warmed PBS, and then fixed with 100μl/well of 
ice-cold  1.0%  paraformaldehyde  for  5  min  at  room  tem-
perature. The plate was washed 3 times with 300μl/well of 
PBS, and B3Z cells were added (2×10
5/well). After incubat-
ing for 4 h at 37
oC, lacZ activity was measured either by col-
orimetric analysis after incubating freeze-thaw lysed cells with 
β-galactosidase substrate, chlorophenol red β-D-galactopyr-
anoside  (Calbiochem,  Darmstadt,  Germany),  as  described 
previously  (20).
MHC class II-restricted presentation assay
BM-DCs were cultured in the presence of different concen-
trations of aspirin or ibuprofen for 18 h in 96-well plates (1 
×10
5/well), and then added with OVA-microspheres (50 μ
g/ml as OVA). After 2 h incubation at 37
oC, unphagocytized 
OVA-microspheres were removed by suction, and then fixed 
with  ice-cold  1.0%  paraformaldehyde  for  5  min  at  room 
temperature. The plate was then washed twice with 300 μl/ 
well of pre-warmed media, and added with DOBW cells (1 
×10
5/well). After 24 h incubation at 37
oC, the plate was cen-
trifuged at 1,800 rpm, and the culture supernatant was col-
lected and assayed for IL-2 content using an IL-2 ELISA kit 
( B D  B i o s c i e n c e s ,  S a n  J o s e ,  C A ) .  
Phagocytosis assay
DCs were cultured in the presence of different concentrations 
of  aspirin  or  ibuprofen  for  18  h  in  6-well  plates  (2×10
6 
cells/well), and then added with microspheres (average diam-
eter,  300  nm)  containing  both  ovalbumin  (OVA)  and  fluo-Cox Inhibitors Block MHC-restricted Antigen Presentation
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Figure 1. Effects of aspirin (A) and ibu-
profen (B) on the cross-presentation of 
exogenous OVA. DC2.4 cells were incu-
bated with the indicated amounts of the 
drugs for 18 h, and then added with 
OVA-microspheres. After 2 h incubation, 
the cells were washed, fixed, and the 
amounts of OVA peptides presented on 
MHC class I molecules were assessed using 
B3Z cells. The amount of β-galactosidase 
expressed in B3Z cells was determined by
an enzymatic assay using chlorophenolred 
β-D-galactopyranoside as a substrate. *p
＜0.05, **p＜0.01 compared with un-
treated control.
rescein isothiocyanate (FITC). After 2 h, unphagocytozed mi-
crospheres were removed by washing with pre-warmed PBS. 
The plate was chilled on ice for 20 min, then the cells were 
harvested  by  treating  with  Cell  stripper  solution  (Cellgro 
Mediatech, Herndon, VA) as suggested in the manufacturer’s 
instruction, fixed in 1% paraformaldehyde in PBS, and flow 
cytometric  analysis  was  performed  on  a  FACS  Calibur  flow 
cytometer  (Becton  Dickinson). 
Phenotypic analysis
DCs were cultured in the presence of different concentrations 
of  aspirin  or  ibuprofen  for  18  h  in  6-well  plates  (2×10
6 
cells/well). The plate was then chilled on ice for 20 min, and 
the cells were harvested by treating with Cell stripper solution 
(Cellgro Mediatech). The cells were stained with monoclonal 
antibodies  recognizing  murine  cell  surface  molecules  after 
blocking  of  FcR-binding  anti-CD16/CD32  monoclonal  anti-
body  (clone  2.4G2),  and  flow  cytometric  analysis  was  per-
formed  on  a  FACS  Caliver  (Becton-Dickinson).  The  mono-
clonal  antibodies,  anti-H-2K
b  (clone  AF6-88.5),  anti-I-A
b 
(clone AF6-120.1), anti-CD40 (clone 3/23), anti-CD54 (clone 
3E2), anti-B7-1 (clone 16-10A1), anti-B7-2 (clone GL1), and 
isotype-matched control antibodies were purchased from BD 
Biosciences. 
RESULTS
Aspirin and ibuprofen block the MHC-restricted 
presentation of exogenous OVA
To examine the effects of the aspirin and ibuprofen on the 
cross-presentation, DC2.4 cells were cultured in the presence 
of  the  drugs  for  18  h,  and  then  allowed  to  phagocytose 
OVA-microspheres for 2 h. The DC2.4 cells were then washed, 
fixed  with  paraformaldehyde,  and  the  amount  of  OVA  pep-
tide-class I MHC complexes was measured using a T cell hy-
bridoma,  B3Z,  which  recognizes  OVA  peptide  (SIINFEKL)- 
H-2K
b complex and expresses β-galactosidase (16). As shown 
in  Fig.  1,  aspirin  inhibited  MHC  class  I-restricted  OVA  pre-
sentation at concentrations of 500μM or above. The inhibitory 
activity  of  ibuprofen  on  MHC  class  I-restricted  OVA  pre-
sentation was observed at concentrations of 250μM or above. 
    The effects of the drugs on the MHC class II-restricted pre-
sentation  of  exogenous  OVA  were  examined  in  DCs  gen-
erated  from  bone  marrow  cells  (BM-DCs)  with  GM-CSF. 
BM-DCs  were  treated  with  different  concentrations  of  the 
drugs for 18 h, and then allowed to phagocytize OVA-micro-
spheres for 2 h. The DCs were then washed, fixed with paraf-
ormaldehyde, and then the amount of OVA peptide-class II 
MHC complexes was measured using OVA-specific CD4 T cell 
hybridoma, DOBW cells. As shown in Fig. 2, aspirin inhibited 
MHC class II-restricted OVA presentation at concentration of 
250μM  or  above.  The  inhibitory  activity  of  ibuprofen  on 
MHC  class  II-restricted  OVA  presentation  was  observed  at 
concentrations  of  125μM  or  above.   
DCs developed in the presence of aspirin or 
ibuprofen are suppressed in the antigen 
presenting function
To examine the effects of aspirin and ibuprofen on the ac-
quisition of antigen presenting function, the drugs were add-
ed  to  DC  differentiation-inducing  cultures  at  different  time 
points,  days  0,  3  and  5  after  the  initiation  of  the  culture. Cox Inhibitors Block MHC-restricted Antigen Presentation
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Figure 2. Effects of aspirin and ibuprofen on 
the class II MHC-restricted presentation of 
exogenous OVA. Indicated amounts of aspirin
or ibuprofen were added to cultures of 
BM-DCs for 18 h, and then added with 
OVA-microspheres. After 2 h incubation, the 
cells were washed, fixed, and the amounts of 
OVA peptides presented on MHC class II 
molecules were assessed using OVA-specific 
CD4 T cell hybridoma, DOBW. The amounts 
of IL-2 produced from OVA-specific CD4 T 
cells were assayed by a commercial IL-2 ELISA
kit. *p＜0.05, **p＜0.01 compared with un-
treated control.
Figure 3. DCs differentiated in the 
presence of aspirin or ibuprofen are 
suppressed in MHC class II-restricted
antigen presentation capability. Indi-
cated amounts of aspirin or ibu-
profen were added to mouse bone 
marrow cells together with GM-CSF 
from the initiation of the DC diffe-
rentiation-inducing culture (day0), at 
3 days (Day3), or at 5 days (day5) 
after the initiation of the cultures. 
BM-DCs were harvested on day 6 
from the initiation of the culture, and
the ability to present exogenous 
antigen in association with MHC 
class II molecules was ascertained as
in Fig. 2.
BM-DCs were harvested on day 6 from the initiation of the 
culture, and the ability to present exogenous antigen in asso-
ciation with MHC class II molecules was examined as in Fig. 
2.  As  shown  in  Fig.  3A,  DCs  generated  from  mouse  bone 
marrow cells in the presence of aspirin from the initiation of 
the culture (Day0) or 3 days after the initiation of the cul-
ture (Day3) were profoundly suppressed in MHC class II-re-
stricted OVA presenting capability. This inhibitory effect of 
aspirin appeared to be dose dependent. When developing 
DCs were exposed to aspirin at a later time point (Day5, 
5 days after the initiation of culture), the suppressive activ-
ity of aspirin on antigen presenting capability was weaker 
compared  to  the  earlier  exposures  (Day0  and  Day3). 
Likewise, DCs generated in the presence of ibuprofen from 
earlier time points of differentiation (Day0 and Day5) were 
significantly  suppressed  in  MHC  class  II-restricted  antigen 
presenting capability. We also found that DCs generated in 
the presence of aspirin or ibuprofen were suppressed in the 
MHC class I-restricted exogenous antigen presentation, and 
the suppressive activities of the drugs were more prominent 
when developing DCs were exposed to the drugs at earlier 
time  points  (data  not  shown). 
Aspirin and ibuprofen do not inhibit the phagocytic 
activity of DCs
T o  e x a m i n e  w h e t h e r  t h e  s u p p r e s s e d  c a p a c i t y  o f  a s p i r i n  o r  
ibuprofen-treated DCs to present OVA peptides in association 
with MHC molecules was due to decreased phagocytic activ-
ity, DC2.4 cells were cultured with the drugs (1 mg/ml) for 
18 h, and then added with microspheres containing both OVA 
and FITC. After 2 h incubation, unphagocytized microspheres 
were washed, and the cells were harvested by gentle pipet-
ting after cooling on ice. Flow cytometric analysis of the har-
vested cells showed that neither of the drugs suppressed the Cox Inhibitors Block MHC-restricted Antigen Presentation
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Figure 4. Effects of aspirin and ibuprofen on the phagocytic activity.
DC2.4 cells were cultured with aspirin or ibuprofen for 18 h, and then
added with microspheres containing both OVA and FITC. After 2 h 
incubation, unphagocytized microspheres were washed, and the cells
were harvested by gentle pipetting, and then analyzed by flow 
cytometry. Shaded histograms represent the phagocytic activity of DCs
cultured in the presence of aspirin or ibuprofen, and thick line 
histograms represent the phagocytic activity of DCs cultured in the 
absence of the drugs. DCs that were not incubated with FITC-labeled 
microspheres are shown as thin line histograms (left).
Figure 5. Effects of aspirin and ibuprofen on the expression of MHC
molecules. DC2.4 cells were cultured with aspirin or ibuprofen for 18
h, and then the cells were harvested by gentle pipetting. The 
expression levels of class I and class II MHC molecules were assessed
using anti-H-2K
b and anti-I-A
b monoclonal antibodies. Shaded 
histograms represent the expression levels of H-2K
b and I-A
b molecules
in DC2.4 cells cultured in the absence of the drugs. Thick line 
histograms represent the expression levels of H-2K
b and I-A
b molecules
in DC2.4 cells cultured in the presence of the drugs.
p h a g o c y t i c  a c t i v i t y  o f  D C 2 . 4  c e l l s  ( F i g .  4 ) .  
Ibuprofen, but not aspirin, slightly increases the 
expression of MHC molecules and co-stimulatory 
molecules
To  examine  whether  the  suppressed  capacity  of  aspirin  or 
ibuprofen-treated DCs to present OVA peptides in association 
with MHC molecules was due to the inhibition of expression 
of MHC molecules on the cell surface, DC2.4 cells were cul-
tured with the drugs (1 mg/ml) 18 h, and then the expression 
levels of MHC class I and class II molecules were determined 
by anti-H-2K
b and anti-I-A
b monoclonal antibodies. As shown 
in Fig. 5, aspirin did not affect the expression of MHC class 
I or class II molecules. Ibuprofen, which inhibited MHC-re-
stricted exogenous OVA presentation, even slightly increased 
the expression of MHC class I and class II molecules. Flow 
cytometric  analysis  for  major  co-stimulatory  molecules  such 
as  B7-1,  B7-2,  and  CD40  also  showed  that  aspirin  did  not 
affect the expression of these co-stimulatory molecules (Fig. 
6). Again, ibuprofen, which inhibited MHC-restricted exoge-
nous  OVA  presentation,  even  slightly  increased  the  ex-
pression of co-stimulatory molecules such as B7-1, B7-2, and 
CD40  (Fig.  6).
DISCUSSION
The present study demonstrates that DCs exposed to aspirin 
or ibuprofen for 18 h are suppressed in MHC-restricted exog-
enous  antigen  presenting  capability.  Aspirin  and  ibuprofen 
significantly inhibited MHC class I-restricted exogenous anti-
gen presenting capability of DCs at doses of 500μM or above 
and of 250μM or above, respectively. The MHC class II-re-
stricted exogenous antigen presenting capability of DCs was 
inhibited  at  lower  concentration  of  the  drugs-250μM  or 
above for aspirin and 125μM or above for ibuprofen. When 
aspirin is used as an anti-inflammatory drug in doses of 1,200 
mg/day, the in vivo therapeutic levels are in between 100∼ 
2,000μM (21). Administration of ibuprofen in doses of 400 
mg three times/day translates to up to 120μM in the plasma 
(22). Taken together, our results suggest that aspirin and ibu-
profen suppress antigen presenting function of DCs at clin-
ically  relevant  concentrations. 
    Because NSAIDs are usually used for prolonged time peri-
ods  in  the  treatment  of  chronic  inflammatory  diseases,  we Cox Inhibitors Block MHC-restricted Antigen Presentation
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Figure 6. Effects of aspirin and ibuprofen on the expression of co-stimulatory molecules. DC2.4 cells were cultured
with aspirin or ibuprofen for 18 h, and then the cells were harvested by gentle pipetting. The expression levels of
co-stimulatory molecules were assessed using monoclonal antibodies recognizing mouse cell surface molecules. Shaded 
histograms represent the expression levels of co-stimulatory molecules in DC2.4 cells cultured in the absence of the
drugs. Thick line histograms represent the expression levels of co-stimulatory molecules in DC2.4 cells cultured in 
the presence of the drugs.
were curious to investigate whether the DCs exposed to aspirin 
or ibuprofen during development could acquire normal func-
tion in terms of antigen processing and presentation. Our re-
sults show that DCs generated from mouse bone marrow cells 
i n  t h e  p r e s e n c e  o f  a s p i r i n  ( 1 0 0 μM)  or  ibuprofen  (100μM) 
from the early stage of differentiation (Day 0 or 3 after the 
differentiation initiation culture) were profoundly suppressed 
in  MHC-restricted  exogenous  antigen  presenting  capability. 
These results suggest that aspirin and ibuprofen, when used 
in prolonged and higher doses, exert suppressive activity on 
adaptive immunity in addition to the well-known mechanism 
of  COX  inhibition. 
    DCs play a key role in the initiation of primary immune 
responses (23-25). DCs can acquire and process antigens in 
the  periphery,  and  migrate  to  secondary  lymphoid  tissues 
w he re  th e y pr im e t he  pri ma ry  T  c e ll re sp on se s.  Th e c apa-
bility of DCs to activate even naïve T cells in a primary re-
sponse  has  been  explained  by  their  ability  to  express  high 
levels  of  MHC  class  II  molecules  and  co-stimulatory  mole-
cules.  The  present  study  shows  that  aspirin  and  ibuprofen 
suppress  MHC  class  II-restricted  antigen  presentation  more 
strongly  than  MHC  class  I-restricted  antigen  presentation  in 
DCs.  The  effects  of  the  expression  of  co-stimulatory  mole-
cules  appeared  to  be  different  between  the  two  drugs. 
Aspirin did not affect the expression of co-stimulatory mole-
cules in DC2.4 cells, whereas ibuprofen slightly increased the 
expression of co-stimulatory molecules. Ibuprofen also slight-
ly increased the expression of MHC class I and class II mole-
cules  in  DC2.4  cells.  Although  ibuprofen  slightly  increased 
the expression of co-stimulatory molecules as well as MHC 
molecules, the DCs treated with ibuprofen were suppressed 
in activating OVA-specific CD4 T cells compared to normal 
DCs. Because T cells can only recognize antigens presented 
i n  t h e  f o r m  o f  s h o r t  p e p t i d e - M H C  c o m p l e x e s  p r e s e n t e d  b y 
professional antigen presenting cells (22-25), inhibition of the 
MHC-restricted antigen presenting function of DCs by ibupro-
fen  might  have  had  significant  effects  in  activating  T  cells.
  In all of the experiments described in the present study, 
DCs were exposed to the drugs for 18 h, and the cells were 
allowed to phagocytose OVA-microspheres for 2 h. The DCs 
were washed to remove unphagocytosed OVA-microspheres, 
fixed  with  paraformaldehyde,  and  then  washed  thoroughly 
again to remove paraformaldehyde before functional assays 
with OVA-specific CD4 or CD8 T cells. Thus, the activation 
of OVA-specific T cells must be due to enhanced expression 
of  OVA peptides  on  DCs,  and not  due  to  the carryover  of 
the  drugs  to  T  cell  cultures.
    In summary, we have demonstrated that aspirin and ibu-
profen at high concentrations inhibit both MHC class I and 
class II-restricted exogenous antigen presentation. In addition, 
we showed that the DCs generated in the presence of these 
drugs  are  profoundly  suppressed  in  MHC-restricted  antigen Cox Inhibitors Block MHC-restricted Antigen Presentation
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presentation capability. These results suggest that aspirin and 
ibuprofen may exert their anti-inflammatory activity by the in-
hibition of the antigen presenting function of DCs in addition 
to the well-known mechanism of COX inhibition, especially 
when  these  drugs  are  used  in  prolonged  durations.
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